# Treat Primary and Metastatic Liver Tumors

> **NCT05240040** · — · WITHDRAWN · sponsor: **Methodist Health System**

## Conditions studied

- Intrahepatic Cholangiocarcinoma
- Liver Tumor
- Metastatic Cancer
- Metastatic Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05240040
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04-26
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Resources
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05240040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05240040, "Treat Primary and Metastatic Liver Tumors". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05240040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*